The Global Newborn Screening and Genetic Services Market was valued at USD 1.75 Billion in 2025 and is projected to reach USD 2.95 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period (2024–2030). This robust growth is being driven by increasing government mandates for newborn screening programs, rising awareness of genetic disorders, and rapid technological advancements in genomic analysis and point-of-care testing.

As the healthcare industry increasingly shifts toward preventative and precision medicine, the spotlight is on the key providers who are developing the critical tests and services that enable early intervention for life-altering conditions. In this blog, we profile the Top 10 Companies in the Newborn Screening and Genetic Services Industry—a mix of diagnostic giants, medical device leaders, and specialized genetic service providers shaping the future of pediatric healthcare.

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

🔟 1. PerkinElmer, Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Dried Blood Spot Screening Kits, Genetic Testing Platforms, Informatics Solutions

PerkinElmer is a global leader in newborn screening, providing comprehensive solutions that cover instruments, reagents, and software. Their platforms are used by public health laboratories in over 100 countries to screen millions of newborns annually for over 50 disorders.

Innovation Initiatives:

• Development of high-throughput tandem mass spectrometry systems

• Expansion of screening panels to include lysosomal storage disorders

• Integrated data management platforms for result reporting and tracking

---

9️⃣ 2. Bio-Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: Hemoglobinopathy Tests, QC Materials, HPLC & MS Systems

Bio-Rad is a cornerstone of the newborn screening ecosystem, particularly renowned for its expertise in hemoglobin disorder detection. Their offerings include the widely used VARIANT™ and D-10™ systems for diagnosing sickle cell disease and thalassemias.

Innovation Initiatives:

• Pioneering non-invasive screening methods

• Automated solutions to enhance laboratory efficiency

• Global health partnerships to expand access in emerging markets

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

8️⃣ 3. Waters Corporation

Headquarters: Milford, Massachusetts, USA
Key Offering: Tandem Mass Spectrometry Systems, Informatics Software

Waters Corporation provides critical analytical instrumentation for metabolomic profiling in newborn screening. Their Xevo™ and X500 series mass spectrometers are industry standards for the sensitive and accurate detection of amino acid, fatty acid oxidation, and organic acid disorders.

Innovation Initiatives:

• Advancing high-resolution mass spectrometry for expanded panels

• Development of streamlined workflows for high-volume testing

---

7️⃣ 4. Masimo Corporation

Headquarters: Irvine, California, USA
Key Offering: Newborn Pulse Oximetry Screening Devices

Masimo specializes in non-invasive patient monitoring technologies, including pulse oximeters used for Critical Congenital Heart Disease (CCHD) screening. Their Radius PPG® and Rad-97® devices are deployed in hospitals worldwide to detect life-threatening heart defects shortly after birth.

Innovation Initiatives:

• Wireless and wearable monitoring for continuous screening

• Integration of SET® pulse oximetry technology for low-perfusion accuracy

---

6️⃣ 5. Trivitron Healthcare

Headquarters: Chennai, India
Key Offering: Newborn Screening Kits, Laboratory Equipment, Turnkey Solutions

Trivitron is a major player in the Asian market, offering a complete portfolio of newborn screening products and services. Through its Labsystems Diagnostics division, it provides affordable and accessible screening solutions tailored for developing economies.

Innovation Initiatives:

• Focus on cost-effective screening for resource-limited settings

• Establishment of newborn screening training centers

• Public-private partnerships to implement national screening programs

---

5️⃣ 6. Natus Medical Incorporated

Headquarters: Pleasanton, California, USA
Key Offering: Hearing Screening Devices, Neurological Monitoring Systems

Natus is a leading provider of hearing screening solutions for newborns. Their products, such as the Algo® and Echo-Screen® devices, are used to detect hearing loss early, which is crucial for language and cognitive development.

Innovation Initiatives:

• Automated ABR and OAE technologies for accurate hearing assessment

• Cloud-based data management for result tracking and follow-up

Download FREE Sample Report:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

4️⃣ 7. Agilent Technologies, Inc.

Headquarters: Santa Clara, California, USA
Key Offering: LC/MS Systems, Microarray Solutions, Reagents

Agilent provides advanced life science tools that support comprehensive genetic analysis in newborn screening labs. Their mass spectrometry and nucleic acid analysis platforms enable the detection of a wide array of inborn errors of metabolism and genetic conditions.

Innovation Initiatives:

• Development of next-generation sequencing (NGS) workflows for screening

• Collaboration with research institutions to validate new biomarkers

---

3️⃣ 8. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Medical Imaging Systems, Patient Monitoring Solutions

While not exclusively a screening company, GE Healthcare’s advanced imaging technologies, such as ultrasound and MRI, play a vital role in the confirmatory diagnosis of conditions flagged during initial newborn screening, particularly for CCHD and metabolic disorders affecting organs.

Innovation Initiatives:

• AI-powered imaging analysis for earlier and more precise diagnosis

• Portable ultrasound devices for use in neonatal intensive care units (NICUs)

---

2️⃣ 9. AB Sciex (Danaher)

Headquarters: Framingham, Massachusetts, USA
Key Offering: Triple Quad and QTRAP Mass Spectrometry Systems

As part of Danaher’s Life Sciences portfolio, AB Sciex is a key supplier of mass spectrometry technology used in high-volume newborn screening laboratories. Their systems are known for robustness and sensitivity, which are critical for reliable metabolite and hormone analysis.

Innovation Initiatives:

• Automated sample preparation systems to reduce manual labor

• Software solutions for simplified data interpretation and reporting

---

1️⃣ 10. Covidien Plc (Medtronic)

Headquarters: Dublin, Ireland (Operational HQ in Mansfield, Massachusetts, USA)
Key Offering: Nellcor™ Pulse Oximetry Systems for CCHD Screening

Medtronic’s Covidien division offers the Nellcor™ brand of pulse oximetry monitors, which are widely adopted for CCHD screening in hospital nurseries. Their technology helps ensure that newborns with critical heart conditions receive prompt, life-saving interventions.

Innovation Initiatives:

• Integration of monitoring data into electronic health records (EHR)

• Development of low-cost sensors to improve accessibility

Get Full Report Here:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Newborn Screening Is More Proactive and Personalized

The newborn screening and genetic services market is undergoing a profound transformation. While traditional biochemical assays and hearing tests remain the foundation, the industry is rapidly embracing genomic technologies, digital health platforms, and AI-driven diagnostics to enable earlier and more comprehensive detection of conditions.

📈 Key Trends Shaping the Market:

• Expansion of screening panels to include rare genetic disorders via Next-Generation Sequencing (NGS)

• Increasing integration of telemedicine for specialist consultation and follow-up care

• Growing emphasis on data interoperability and lifelong health records

• Rising public and private investments in genomic research and public health infrastructure

Get Full Report Here:
Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

The companies listed above are not only providing essential screening tools—they are building the foundation for a future where every child has the best possible start in life through early detection and personalized intervention.